Aridis Pharmaceuticals: Better Alternative to Traditional Antibiotics?
Aridis Pharmaceuticals is a private biotechnology company focusing on improved alternatives to traditional antibiotics for the treatment of pneumonia and Cystic Fibrosis in addition to a few other conditions.
Read more »Inhalable Drugs Let Patients Take a Breather from Needles
Earlier this month, a team of researchers led by the University of Colorado at Boulder announced that the inhalable measles vaccine they developed could lead to vaccines for other diseases.
Read more »FDA Grants Luminex 510(k) Clearance for Cystic Fibrosis Test
The xTAG Cystic Fibrosis 39 Kit v2 is intended to be a faster, more convenient way to screen for CF.
Read more »